![Toyomasa Katagiri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toyomasa Katagiri
Directeur/Membre du Conseil chez
Cancer Precision Medicine KK
Profil
Toyomasa Katagiri is currently the Director at Immunas Pharma, Inc. since 2014, Professor & Deputy Director at The University of Tokushima since 2008, and Director at Cancer Precision Medicine KK since 2018.
Previously, he served as an Outside Director at OncoTherapy Science, Inc. from 2010 to 2023.
Postes actifs de Toyomasa Katagiri
| Sociétés | Poste | Début |
|---|---|---|
The University of Tokushima
 The University of Tokushima Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/05/2008 |
Cancer Precision Medicine KK | Directeur/Membre du Conseil | 01/05/2018 |
Anciens postes connus de Toyomasa Katagiri
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Directeur/Membre du Conseil | 31/03/2023 |
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody medicines | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
OncoTherapy Science, Inc.
 OncoTherapy Science, Inc. BiotechnologyHealth Technology Engages in the research and development of cancer vaccines and antibody drugs | Health Technology |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody medicines | Health Technology |
The University of Tokushima
The University of Tokushima Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Precision Medicine KK |
Choisissez Zonebourse 
